Title:
LIQUID FORMULATION COMPRISING A FUSION PROTEIN INCLUDING α-GALACTOSIDASE A
Document Type and Number:
WIPO Patent Application WO/2023/177158
Kind Code:
A1
Abstract:
The present invention relates to a liquid formulation including a fusion protein of α-galactosidase A and a preparation method thereof, wherein the liquid formulation not only has storage stability by including a composition providing structural stability to a fusion protein of α-galactosidase A, but also has excellent stability although the fusion protein is contained at a high concentration.
Inventors:
KIM MIROO (KR)
YOO MIRI (KR)
SON JAE WOON (KR)
PARK DA-EUI (KR)
YI SHIN-AE (KR)
KIM JIN YOUNG (KR)
PARK JUN SUB (KR)
JANG DOO SEO (KR)
HONG SUNG HEE (KR)
KIM SANG YUN (KR)
YOO MIRI (KR)
SON JAE WOON (KR)
PARK DA-EUI (KR)
YI SHIN-AE (KR)
KIM JIN YOUNG (KR)
PARK JUN SUB (KR)
JANG DOO SEO (KR)
HONG SUNG HEE (KR)
KIM SANG YUN (KR)
Application Number:
PCT/KR2023/003299
Publication Date:
September 21, 2023
Filing Date:
March 10, 2023
Export Citation:
Assignee:
GREEN CROSS CORP (KR)
HANMI PHARM IND CO LTD (KR)
HANMI PHARM IND CO LTD (KR)
International Classes:
A61K9/08; A61K9/00; A61K38/47; A61K47/02; A61K47/12; A61K47/18; A61K47/22; A61K47/26; A61K47/68; A61P3/00
Domestic Patent References:
| WO2008084237A2 | 2008-07-17 | |||
| WO2015009052A1 | 2015-01-22 |
Foreign References:
| US20210252112A1 | 2021-08-19 | |||
| US20210009984A1 | 2021-01-14 | |||
| US20140127227A1 | 2014-05-08 |
Attorney, Agent or Firm:
HANOL INTELLECTUAL PROPERTY & LAW (KR)
Download PDF: